findmyKOL
Clinical trialNCT00003149CompletedPhase 2Interventional

Interleukin-12 in Treating Patients With Multiple Myeloma

SponsorEastern Cooperative Oncology GroupEnrollment40Multiple Myeloma and Plasma Cell Neoplasm
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Indiana University Cancer Center

    Indianapolis, Indiana, United States

  • Veterans Affairs Medical Center - Indianapolis (roudebush)

    Indianapolis, Indiana, United States

  • Ccop - Iowa Oncology Research Association

    Des Moines, Iowa, United States

  • Ccop - Ochsner

    New Orleans, Louisiana, United States

  • Mayo Clinic Cancer Center

    Rochester, Minnesota, United States

  • Hunterdon Regional Cancer Center

    Flemington, New Jersey, United States

  • Morristown Memorial Hospital

    Morristown, New Jersey, United States

  • Overlook Hospital

    Summit, New Jersey, United States

  • University of Rochester Cancer Center

    Rochester, New York, United States

  • Hahnemann University Hospital

    Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 1997
Primary completion
Completion
30 Sept 2006
Last update posted
21 Jun 2013
Registered enrollment
40
Registry id
NCT00003149

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.